Health

Results: 613-624 of 10111

Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award

Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award

AMRA Medical - Measuring Muscles with Quantitative MRI

Measuring Muscles with Quantitative MRI: New Study Published in Neurology Expands the Evidence for Using MRI Biomarkers in SBMA

PR Newswire associated0

DarwinHealth Introduces Quantum Cancer Biology: A Cell-State Systems Biology Framework for Precision Oncology

PENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Assisted Colonoscopy Worldwide

PR Newswire associated0

Jazz Pharmaceuticals Announces Private Offering of $1.0 Billion of Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases

THRIVING IN MIDLIFE

Friends sit and laugh while having a drink

Bank holiday weekend puts Britain’s moderation habits to the test as new data shows binge drinking is on the rise

The scale of the global diabetes crisis is expanding. In line with this trend, the global demand for insulin needles continues to escalate. Furthermore, insulin delivery is evolving toward "painless" experiences that reduce patient burden. Modern designs prioritize minimizing pain and bruising, leading to the widespread adoption of ultra-fine needles. This trend is further supported by the growing popularity of compact, portable pen injectors. Additionally, the global rise in weight-management medications—which also utilize these ultra-fine needles—is further accelerating market expansion. We supply NK-304NKM, a specialized stainless steel for thin-walled welded tubes used in medical and cosmetic applications, most notably for "painless needles". This material offers a superior combination of stable weldability and excellent drawability. Our quality advantage is highly recognized and valued throughout the global market.

NIPPON KINZOKU Establishes Mass Production of Ultra-Thin and Narrow Stainless Steel for Insulin Needles

VirTus Respiratory Research Supports Development of Apollo Therapeutics’ APL-10456 from Preclinical Proof of Concept to Positive Phase 1 Data

BioArctic: Interim Report for the period April - June 2026

BeOne Medicines Announces U.S. FDA Approval for TEVIMBRA-Based Regimen for First-Line HER2+ GEA

Envision Pharma Group Names Ryan Tubbs, Senior Vice President, Commercial Growth